EUXS:LSE:LSE-iShares MSCI Europe Ex UK GBP (GBX)

ETF | Others |

Last Closing

USD 737.75

Change

-5.25 (-0.71)%

Market Cap

USD 0.12B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-1.75 (-0.94%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-3.13 (-2.62%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.02 (-0.12%)

USD 572.76B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.12 (+0.87%)

USD 572.76B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.45 (+0.63%)

USD 266.08B
0QZO:LSE 0QZO

-1.75 (-1.83%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

-0.04 (-0.13%)

USD 208.06B
0QZ3:LSE Qualcomm Inc.

-1.75 (-1.04%)

USD 202.26B
0R24:LSE Intel Corp.

-0.81 (-3.45%)

USD 196.14B

ETFs Containing EUXS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.56% 58% F 60% D-
Dividend Return 0.02% 20% F 30% F
Total Return 9.58% 57% F 60% D-
Trailing 12 Months  
Capital Gain 19.63% 59% D- 61% D-
Dividend Return 0.03% 22% F 28% F
Total Return 19.66% 58% F 61% D-
Trailing 5 Years  
Capital Gain 44.84% 61% D- 69% C-
Dividend Return 1.88% 35% F 40% F
Total Return 46.73% 61% D- 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 9.17% N/A N/A 67% D+
Dividend Return 9.51% N/A N/A 67% D+
Total Return 0.34% N/A N/A 49% F
Risk Return Profile  
Volatility (Standard Deviation) 14.49% N/A N/A 65% D
Risk Adjusted Return 65.67% N/A N/A 83% B
Market Capitalization 0.12B 52% F 29% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike